Medicamen Biotech News

Medicamen Biotech concludes 33rd AGM

Medicamen Biotech held its 33rd AGM via video conferencing on September 26, 2026. The meeting adopted FY26 financial statements and approved dividend declarations.

Shivalik Rasayan holds 40.46% stake in Medicamen Biotech

Promoter Shivalik Rasayan Limited holds 54,87,095 equity shares, or 40.46%, in Medicamen Biotech Limited as of March 31, 2026. No shares were encumbered during FY26.

Medicamen Biotech board meets May 27

Medicamen Biotech Limited's board will meet on May 27, 2026, to consider audited financial results for FY26 and a final dividend. The meeting will also address auditor appointments for FY27.

Medicamen Biotech Files Q4FY26 Compliance Certificate

Medicamen Biotech Limited submitted its quarterly compliance certificate under SEBI regulations for securities dematerialization activities during Q4FY26 ended March 31, 2026.

Medicamen Biotech clarifies incorrect NSDL event

Medicamen Biotech Limited has clarified that an event displayed on NSDL portal under company credentials was inadvertent and incorrect, with no such event initiated by the company.